SENSENIG BETHANY sold 5.37K shares of SUPERNUS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $226.8K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/18/2025ACC: 0001628280-25-040668
Director
Since Feb 2026
-5.37K
Net shares
Net seller
$226.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
5.37K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−5.37K
Price / share
$42.25
Trade value
$226.84K
% of position
New position
8/14/2025
5.37K→0.00
Total
Net shares
−5.37K
Net value
-$226.84K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/14/2025 | S · Sale | −5.37K | $42.25 | $226.84K | New position | 5.37K | 0.00 |
| Total | −5.37K | -$226.84K | ||||||
Derivative Transactions0
No derivative transactions reported